Protagonist Therapeutics, Inc·4

Apr 24, 4:10 PM ET

PATEL DINESH V PH D 4

4 · Protagonist Therapeutics, Inc · Filed Apr 24, 2026

Research Summary

AI-generated summary of this filing

Updated

Protagonist Therapeutics (PTGX) CEO Dinesh Patel Gifts 1,460 Shares

What Happened Dinesh V. Patel, Ph.D., President, CEO and Director of Protagonist Therapeutics (PTGX), reported a gift disposition of 1,460 common shares on 2026-04-23. The filing shows the shares were transferred as a bona fide gift (transaction code G) with a reported price of $0.00 and aggregate value $0.

Key Details

  • Transaction date: 2026-04-23; Filing date: 2026-04-24 (timely filing).
  • Transaction type/code: Gift (G); reported as a disposal (no cash proceeds).
  • Shares disposed: 1,460; reported price per share: $0.00; total reported value: $0.
  • Footnote: F1 — the transaction involves a bona fide gift of securities to family and friends.
  • Shares owned after transaction: Not specified in the provided filing details.

Context Gifts are transfers for personal reasons (to family/friends) and do not necessarily reflect the insider’s view of the company’s prospects. This was not a sale or purchase; it’s a non‑market transfer reported for disclosure and compliance.

Insider Transaction Report

Form 4
Period: 2026-04-23
PATEL DINESH V PH D
DirectorPresident and CEO
Transactions
  • Gift

    Common Stock

    [F1]
    2026-04-231,460523,478 total
Footnotes (1)
  • [F1]This transaction involves a bona fide gift of securities from the Reporting Person to family and friends.
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Dinesh V. Patel, Ph.D.|2026-04-24

Documents

1 file
  • 4
    tm2612651-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT